| Role |
Name |
Disclosure |
Details |
| Author | Adrienne Rencic, MD, PhD, FAAD, Consulting Staff, Department of Dermatology, Riddle Memorial Hospital | Nothing to disclose | Details | | Coauthor | Jeyanthi Ramanarayanan, MD, Attending Physician, Department of Medicine, Division of Hematology and Medical Oncology, Stratton Veterans Affairs Medical Center | Nothing to disclose | Details | | Medical Editor | Noah S Scheinfeld, MD, JD, FAAD, Assistant Clinical Professor, Department of Dermatology, Columbia University; Consulting Staff, Department of Dermatology, St Luke's Roosevelt Hospital Center, Beth Israel Medical Center, New York Eye and Ear Infirmary; Private Practice | Optigenex | Details | | Pharmacy Editor | David F Butler, MD, Professor of Dermatology, Texas A&M University College of Medicine; Director, Division of Dermatology, Scott and White Clinic; Director Dermatology Residency Training Program, Scott and White Clinic | 3M Pharmaceutical Graceway Pharmaceuticals | Details | | Managing Editor | Jeffrey J Miller, MD, Associate Professor, Department of Dermatology, Penn State University, Milton S Hershey Medical Center | Nothing to disclose | Details | | CME Editor | Joel M Gelfand, MD, MSCE, Medical Director, Clinical Studies Unit, Assistant Professor, Department of Dermatology, Associate Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania | AMGEN AMGEN Genentech Centocor Centocor Covance Shire | Details | | Chief Editor | Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Jeffrey J Miller, Managing Editor |
The contributor discloses no conflict of interest. |
|